Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.
about
Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammationElevated serum neutrophil elastase is related to prehypertension and airflow limitation in obese women.Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.Hhip haploinsufficiency sensitizes mice to age-related emphysemaInnate and acquired immunity in the human penile urethraMepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.A novel nonhuman primate model of cigarette smoke-induced airway diseasePeptides in Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease.Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.Airway mucus: From production to secretion.Molecular pathogenesis of emphysemaThe stumbling block in lung repair of emphysema: elastic fiber assemblyMatrix metalloproteinases in lung: multiple, multifarious, and multifaceted.Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease.Current concepts in mechanisms of emphysema.Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide speciesHost defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatment.Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.Treating COPD with PDE 4 inhibitors.Matrix Remodeling in Pulmonary Fibrosis and Emphysema.Ascorbate attenuates pulmonary emphysema by inhibiting tobacco smoke and Rtp801-triggered lung protein modification and proteolysis.A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β-CateninSystemic consequences of COPD.Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease.The role of oxidative stress in COPD: current concepts and perspectives.Toll-like receptor 4 deficiency causes pulmonary emphysema.Extracellular catalase activity protects cysteine cathepsins from inactivation by hydrogen peroxide.Pulmonary epithelial neuropilin-1 deletion enhances development of cigarette smoke-induced emphysema.Regulation of cathepsin K activity by hydrogen peroxide.Ligand-based virtual screening and molecular docking studies to identify the critical chemical features of potent cathepsin D inhibitors.Elastin receptor (S-gal) occupancy by elastin peptides modulates T-cell response during murine emphysema.COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series).Club cell protein 16 (Cc16) deficiency increases inflamm-aging in the lungs of mice
P2860
Q24615052-28E9B9D7-E1FC-43F8-820D-F779F3DD6BB6Q33797345-DBE3446B-68B3-4808-BE5E-E032A26565D8Q34043367-49724421-9A9A-40CE-9AAD-4F01641A84D2Q34447908-AB233FC8-5ADC-41AD-ADAB-C9FF1F249394Q34534888-21DF73C6-52CB-43BB-93F6-1B7FE36686C6Q34726804-6EEC7018-F64F-4548-92BC-11FC707EB8DEQ35031623-566254B5-B0D4-41DB-98CA-832AEB438ECAQ35143749-D4C7F1E0-C5AB-4F77-AB1C-140A5FDD1BCDQ36030300-FEC32FAA-6CDD-4554-9516-75EBE15D8CDAQ36112558-C687236A-83D1-46D3-B04E-24AE227AA6F2Q36369409-9839B543-0D9A-4DBC-84EC-A0A9D7C10BF0Q36407009-C84AD646-7D68-43B0-8086-11B3A5ADA00DQ36518608-FC8505AD-E66F-43FA-8829-92F6670E919CQ36712749-C44F8782-9636-454F-A90C-684B2A60D4D2Q36740428-5C526D68-9912-4D13-A18E-B5F03854DC5BQ36746478-A407B8E4-D10B-4741-BCC5-79B70C5AF828Q36760903-9B8F1711-5221-45B0-9953-1DE56B69A55EQ36801673-52F15D12-B10D-4BDC-B239-9BBE43BF4B04Q37030665-320A2E3F-A773-484D-90C9-D888AF5CE118Q37070325-A35C29A0-6C65-4FC1-BEBC-07C6A5D1D21AQ37082594-44BF84E4-4F91-4F6A-AA6A-219D4DD7D883Q37088316-4DFF383A-E840-4F0D-AA9D-7B6DAFFC14F7Q37126606-6CDD5C59-71F0-4A5D-8864-B67734219B4CQ37213583-69965B8A-6A5F-48D6-A600-B7DFC1CB2E2EQ37362575-52426513-FACA-49DD-8327-638F6FC0B0AEQ37670228-2EA529D9-0682-407D-9C5D-83D440D9667BQ37686174-B9D3BE1E-D83B-4BCC-A8D0-3B074FCF640FQ38743977-A3DFA407-F94C-479A-9697-F3C606923F1EQ40002125-DF6E4033-627E-462A-A1A7-E9E4766D0CCFQ42553543-EE72FCAD-1CF6-4D9C-9A3B-1AE9DEDD46B4Q46268059-7C0A696B-64C9-43C5-B9E1-03ED0F9A3070Q46590926-E6D36651-B89E-414A-BBDB-ABFAC4CAD38FQ50964282-EA5DF769-EA5B-48CC-B016-3247A7315583Q52731057-301A8273-0825-4129-8B7E-88D9426781F0Q58799495-59EB2C05-5596-4CF3-8527-6E0CDA16C220
P2860
Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@ast
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@en
type
label
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@ast
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@en
prefLabel
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@ast
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@en
P2860
P1476
Proteinases and oxidants as ta ...... obstructive pulmonary disease.
@en
P2093
Caroline A Owen
P2860
P304
373-85; discussion 394-5
P356
10.1513/PATS.200504-029SR
P577
2005-01-01T00:00:00Z